Imaging of early modification in cardiomyopathy: the doxorubicin-induced model (Q38112616)

29 August 2017

title

Imaging of early modification in cardiomyopathy: the doxorubicin-induced model (English)

1 reference

29 August 2017

1 reference

3

Farida Cheriet

1 reference

29 August 2017

Mohamed Aissiou

1

1 reference

29 August 2017

Delphine Périé

2

1 reference

29 August 2017

Nagib S Dahdah

4

1 reference

29 August 2017

Caroline Laverdière

5

1 reference

29 August 2017

Daniel Curnier

6

1 reference

29 August 2017

publication date

7 June 2013

1 reference

The International Journal of Cardiovascular Imaging

29 August 2017

published in

1 reference

29 August 2017

volume

29

1 reference

29 August 2017

issue

7

1 reference

29 August 2017

page(s)

1459-1476

1 reference

Doxorubicin cardiomyopathy

29 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS10554-013-0248-0

Anthracyclines: molecular advances and pharmacologic developments in antitumor activity and cardiotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10554-013-0248-0

A clinicopathologic analysis of adriamycin cardiotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10554-013-0248-0

A comparative pharmacokinetic study of doxorubicin and 4'-epi-doxorubicin in children with acute lymphocytic leukemia using a limited sampling procedure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10554-013-0248-0

Risk factors for doxorubicin-induced congestive heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10554-013-0248-0

Chronic progressive cardiac dysfunction years after doxorubicin therapy for childhood acute lymphoblastic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10554-013-0248-0

Anthracycline cardiotoxicity: from bench to bedside

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10554-013-0248-0

Genotyping the risk of anthracycline-induced cardiotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10554-013-0248-0

Genetic polymorphisms in the carbonyl reductase 3 gene CBR3 and the NAD(P)H:quinone oxidoreductase 1 gene NQO1 in patients who developed anthracycline-related congestive heart failure after childhood cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10554-013-0248-0

Anthracycline-related cardiomyopathy after childhood cancer: role of polymorphisms in carbonyl reductase genes--a report from the Children's Oncology Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10554-013-0248-0

Molecular mechanisms of doxorubicin-induced cardiomyopathy. Selective suppression of Reiske iron-sulfur protein, ADP/ATP translocase, and phosphofructokinase genes is associated with ATP depletion in rat cardiomyocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10554-013-0248-0

Early detection of doxorubicin cardiomyopathy using two-dimensional strain echocardiography

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10554-013-0248-0

Beneficial role of aminoguanidine on acute cardiomyopathy related to doxorubicin-treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10554-013-0248-0

Monitoring chemotherapy-induced cardiotoxicity: role of cardiac nuclear imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10554-013-0248-0

Late doxorubicin-associated cardiotoxicity in children. The possible role of intercurrent viral infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10554-013-0248-0

Left ventricular diastolic function after anthracycline chemotherapy in childhood: relation with systolic function, symptoms, and pathophysiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10554-013-0248-0

Left ventricular transmural systolic function by high-sensitivity velocity measurement "phased-tracking method" across the septum in doxorubicin cardiomyopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10554-013-0248-0

Cardiac toxicity 4 to 20 years after completing anthracycline therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10554-013-0248-0

Subclinical late cardiomyopathy after doxorubicin therapy for lymphoma in adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10554-013-0248-0

Late cardiac effects of doxorubicin therapy for acute lymphoblastic leukemia in childhood

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10554-013-0248-0

Response of doxorubicin-induced cardiomyopathy to the current management strategy of heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10554-013-0248-0

Pathophysiology of anthracycline- and radiation-associated cardiomyopathies: implications for screening and prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10554-013-0248-0

Doxorubicin cardiac dysfunction: effects on calcium regulatory proteins, sarcoplasmic reticulum, and triiodothyronine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10554-013-0248-0

Late cardiotoxicity after low dose of anthracycline therapy for acute lymphoblastic leukemia in childhood

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10554-013-0248-0

Anthracycline-induced cardiotoxicity in children and young adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10554-013-0248-0

Doxorubicin-induced apoptosis in spontaneously hypertensive rats: differential effects in heart, kidney and intestine, and inhibition by ICRF-187.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10554-013-0248-0

Adriamycin-induced oxidative mitochondrial cardiotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10554-013-0248-0

Potent metalloporphyrin peroxynitrite decomposition catalyst protects against the development of doxorubicin-induced cardiac dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10554-013-0248-0

Cardioprotective activity of melatonin and its novel synthesized derivatives on doxorubicin-induced cardiotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10554-013-0248-0

Dietary nitrate supplementation protects against Doxorubicin-induced cardiomyopathy by improving mitochondrial function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10554-013-0248-0

Malondialdehyde and thiobarbituric acid-reactivity as diagnostic indices of lipid peroxidation and peroxidative tissue injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10554-013-0248-0

Doxorubicin-induced cardiomyopathy from the cardiotoxic mechanisms to management

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10554-013-0248-0

NADPH cytochrome P-450 reductase activation of quinone anticancer agents to free radicals

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10554-013-0248-0

Mitochondrial dysfunction is an early indicator of doxorubicin-induced apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10554-013-0248-0

Resveratrol prevents doxorubicin cardiotoxicity through mitochondrial stabilization and the Sirt1 pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10554-013-0248-0

Mitochondrial proliferation during apoptosis induced by anticancer agents: effects of doxorubicin and mitoxantrone on cancer and cardiac cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10554-013-0248-0

Doxorubicin inactivates myocardial cytochrome c oxidase in rats: cardioprotection by Mito-Q

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10554-013-0248-0

DNA damage is an early event in doxorubicin-induced cardiac myocyte death

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10554-013-0248-0

Doxorubicin-induced apoptosis: implications in cardiotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10554-013-0248-0

Activation of nuclear factor-kappaB during doxorubicin-induced apoptosis in endothelial cells and myocytes is pro-apoptotic: the role of hydrogen peroxide

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10554-013-0248-0

Doxorubicin induces apoptosis in normal and tumor cells via distinctly different mechanisms. intermediacy of H(2)O(2)- and p53-dependent pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10554-013-0248-0

Two distinct modes of cell death induced by doxorubicin: apoptosis and cell death through mitotic catastrophe accompanied by senescence-like phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10554-013-0248-0

NADPH oxidases participate to doxorubicin-induced cardiac myocyte apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10554-013-0248-0

Comparison of anthracycline-induced death of human leukemia cells: programmed cell death versus necrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10554-013-0248-0

Inhibition of ErbB2 by receptor tyrosine kinase inhibitors causes myofibrillar structural damage without cell death in adult rat cardiomyocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10554-013-0248-0

Doxorubicin cardiomyopathy is associated with a decrease in calcium release channel of the sarcoplasmic reticulum in a chronic rabbit model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10554-013-0248-0

Calcium cycling and signaling in cardiac myocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10554-013-0248-0

Doxorubicin-induced cardiomyopathy: from molecular mechanisms to therapeutic strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10554-013-0248-0

A concise description of cardioprotective strategies in doxorubicin-induced cardiotoxicity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10554-013-0248-0

Monitoring for cardiovascular disease in survivors of childhood cancer: report from the Cardiovascular Disease Task Force of the Children's Oncology Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10554-013-0248-0

Assessment of dexrazoxane as a cardioprotectant in doxorubicin-treated children with high-risk acute lymphoblastic leukaemia: long-term follow-up of a prospective, randomised, multicentre trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10554-013-0248-0

Functional monitoring of anthracycline cardiotoxicity: a prospective, blinded, long-term observational study of outcome in 120 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10554-013-0248-0

Cardiotoxicity of anticancer drugs: the need for cardio-oncology and cardio-oncological prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10554-013-0248-0

Diagnosis of anthracycline-induced late cardiomyopathy by exercise-spiroergometry and stress-echocardiography

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10554-013-0248-0

Screening adult survivors of childhood cancer for cardiomyopathy: comparison of echocardiography and cardiac magnetic resonance imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10554-013-0248-0

Assessments of right ventricular volume and function using three-dimensional echocardiography in older children and adults with congenital heart disease: comparison with cardiac magnetic resonance imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10554-013-0248-0

Myocardial strain analysis in a doxorubicin-induced cardiomyopathy model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10554-013-0248-0

Tissue Doppler imaging and conventional echocardiography after anthracycline treatment in adults: early and late alterations of left ventricular function during a prospective study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10554-013-0248-0

Interobserver, intraobserver and intrapatient reliability scores of myocardial strain imaging with 2-d echocardiography in patients treated with anthracyclines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10554-013-0248-0

Pretreatment and routine echocardiogram monitoring during chemotherapy for anthracycline-induced cardiotoxicity rarely identifies significant cardiac dysfunction or alters treatment decisions: a 5-year review at a single pediatric oncology center

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10554-013-0248-0

Exercise echocardiography in the detection of anthracycline cardiotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10554-013-0248-0

The echocardiographic Tei-index reflects early myocardial damage induced by anthracyclines in patients with hematological malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10554-013-0248-0

Value of real time three-dimensional echocardiography in patients with hypertrophic cardiomyopathy: comparison with two-dimensional echocardiography and magnetic resonance imaging.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10554-013-0248-0

3D echocardiography: a review of the current status and future directions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10554-013-0248-0

Contrast echocardiography: current and future applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10554-013-0248-0

Clinical characteristics and cardiovascular magnetic resonance findings in stress (takotsubo) cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10554-013-0248-0

Detection and monitoring of cardiotoxicity-what does modern cardiology offer?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10554-013-0248-0

Comparison of long and short axis quantification of left ventricular volume parameters by cardiovascular magnetic resonance, with ex-vivo validation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10554-013-0248-0

ACCF/ACR/AHA/NASCI/SCMR 2010 expert consensus document on cardiovascular magnetic resonance: a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10554-013-0248-0

Multi-parametric MRI as an indirect evaluation tool of the mechanical properties of in-vitro cardiac tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10554-013-0248-0

Modelling passive diastolic mechanics with quantitative MRI of cardiac structure and function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10554-013-0248-0

Imaging three-dimensional myocardial mechanics using navigator-gated volumetric spiral cine DENSE MRI

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10554-013-0248-0

Computational cardiac atlases: from patient to population and back

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10554-013-0248-0

The Cardiac Atlas Project--an imaging database for computational modeling and statistical atlases of the heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10554-013-0248-0

Myocardial deformation recovery from cine MRI using a nearly incompressible biventricular model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10554-013-0248-0

Estimation of tissue contractility from cardiac cine-MRI using a biomechanical heart model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10554-013-0248-0

Patient-specific modeling of dyssynchronous heart failure: a case study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10554-013-0248-0

Assessment of myocardial fibrosis with cardiovascular magnetic resonance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10554-013-0248-0

T1 mapping in patients with acute myocardial infarction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10554-013-0248-0

Myocardial T1 mapping: application to patients with acute and chronic myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10554-013-0248-0

T2 quantification for improved detection of myocardial edema

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10554-013-0248-0

Utility of T2-weighted short-tau inversion recovery (STIR) sequences in cardiac MRI: an overview of clinical applications in ischaemic and non-ischaemic heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10554-013-0248-0

Cardiac iron determines cardiac T2*, T2, and T1 in the gerbil model of iron cardiomyopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10554-013-0248-0

Quantification of myocardial iron overload by cardiovascular magnetic resonance imaging T2* and review of the literature.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10554-013-0248-0

Assessment of magnetization transfer effects in myocardial tissue using balanced steady-state free precession (bSSFP) cine MRI.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10554-013-0248-0

Calcium-sensitive MRI contrast agents based on superparamagnetic iron oxide nanoparticles and calmodulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10554-013-0248-0

A fast and effective method to assess myocardial necrosis by means of contrast magnetic resonance imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10554-013-0248-0

Molecular MRI of cardiomyocyte apoptosis with simultaneous delayed-enhancement MRI distinguishes apoptotic and necrotic myocytes in vivo: potential for midmyocardial salvage in acute ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10554-013-0248-0

Subendocardial late gadolinium enhancement in two patients with anthracycline cardiotoxicity following treatment for Ewing's sarcoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10554-013-0248-0

Manganese-enhanced MRI of mouse heart during changes in inotropy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10554-013-0248-0

Manganese ions as intracellular contrast agents: proton relaxation and calcium interactions in rat myocardium

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10554-013-0248-0

Monitoring dynamic alterations in calcium homeostasis by T (1)-weighted and T (1)-mapping cardiac manganese-enhanced MRI in a murine myocardial infarction model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10554-013-0248-0

Calcium fluxes involved in control of cardiac myocyte contraction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10554-013-0248-0

Clinical cardiac magnetic resonance spectroscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10554-013-0248-0

Recommendations for the evaluation of left ventricular diastolic function by echocardiography

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10554-013-0248-0

Contrast echocardiography: evidence-based recommendations by European Association of Echocardiography

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10554-013-0248-0

Dobutamine Stress Echocardiography Identifies Anthracycline Cardiotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10554-013-0248-0

Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardio

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10554-013-0248-0

Noninvasive detection of myocardial fibrosis in arrhythmogenic right ventricular cardiomyopathy using delayed-enhancement magnetic resonance imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10554-013-0248-0

Degradation of NFAT5, a transcriptional regulator of osmotic stress-related genes, is a critical event for doxorubicin-induced cytotoxicity in cardiac myocytes

21 January 2018

1 reference

12 December 2020

Cardiotoxicity of epirubicin and doxorubicin: assessment by endomyocardial biopsy

1 reference

12 December 2020

Antioxidants protect against reactive oxygen species associated with adriamycin-treated cardiomyocytes

1 reference

12 December 2020

The cardiotoxicity of chemotherapeutic drugs

1 reference

12 December 2020

Adriamycin-induced early changes in myocardial antioxidant enzymes and their modulation by probucol

1 reference

12 December 2020

Clinical and morphologic cardiac findings after anthracycline chemotherapy. Analysis of 64 patients studied at necropsy

1 reference

12 December 2020

The late consequences of anthracycline treatment on left ventricular function after treatment for childhood cancer

1 reference

12 December 2020

Evaluation of diffuse myocardial fibrosis in heart failure with cardiac magnetic resonance contrast-enhanced T1 mapping

1 reference

12 December 2020

Acute doxorubicin cardiotoxicity involves cardiomyocyte apoptosis

1 reference

12 December 2020

Reactive oxygen species mediate doxorubicin induced p53-independent apoptosis

1 reference

12 December 2020

Anthracycline cardiomyopathy monitored by morphologic changes

1 reference

12 December 2020

Patterns of interaction between anthraquinone drugs and the calcium-release channel from cardiac sarcoplasmic reticulum

1 reference

12 December 2020

Acute and chronic cardiovascular effects of doxorubicin in the dog: the cardiovascular pharmacology of drug-induced histamine release.

1 reference

12 December 2020

Stimulation of mouse heart and liver microsomal lipid peroxidation by anthracycline anticancer drugs: characterization and effects of reactive oxygen scavengers

1 reference

12 December 2020

Exercise echocardiography reflects cumulative anthracycline exposure during childhood

1 reference

12 December 2020

Anthracycline-induced suppression of GATA-4 transcription factor: implication in the regulation of cardiac myocyte apoptosis

1 reference

12 December 2020

Anthracycline-induced cardiotoxicity: clinical course, risk factors, pathogenesis, detection and prevention--review of the literature

1 reference

12 December 2020

New index of combined systolic and diastolic myocardial performance: a simple and reproducible measure of cardiac function--a study in normals and dilated cardiomyopathy

1 reference

12 December 2020

Delayed contrast enhancement of MRI in hypertrophic cardiomyopathy

1 reference

12 December 2020

Cumulative and irreversible cardiac mitochondrial dysfunction induced by doxorubicin

1 reference

12 December 2020

Subclinical cardiotoxic effects of anthracyclines as assessed by magnetic resonance imaging-a pilot study

1 reference

12 December 2020

Doxorubicin-induced cardiomyopathy

1 reference

12 December 2020

Quantitative assessment of myocardial T2 relaxation times in cardiac amyloidosis

1 reference

12 December 2020

Daunorubicin cardiotoxicity: evidence for the importance of the quinone moiety in a free-radical-independent mechanism

1 reference

12 December 2020

Cardiorespiratory exercise capacity and its relation to a new Doppler index in children previously treated with anthracycline

1 reference

12 December 2020

Redox cycling of anthracyclines by cardiac mitochondria. I. Anthracycline radical formation by NADH dehydrogenase.

1 reference

12 December 2020

Manganese dipyridoxyl-diphosphate (MnDPDP) as a viability marker in patients with myocardial infarction

1 reference

12 December 2020

Adriamycin: the role of lipid peroxidation in cardiac toxicity and tumor response

1 reference

12 December 2020

Length-dependent tension in the failing heart and the efficacy of cardiac resynchronization therapy

1 reference

12 December 2020

Protective effect of Gingko biloba extract against doxorubicin-induced cardiotoxicity in mice.

1 reference

12 December 2020

Sarcoplasmic reticulum calcium release is stimulated and inhibited by daunorubicin and daunorubicinol

1 reference

12 December 2020

The cardiotoxicity of anticancer agents.

1 reference

12 December 2020

Unexpected doxorubicin-mediated cardiotoxicity in sisters: possible role of polymorphisms in histamine n-methyl transferase

1 reference

12 December 2020

Clinical impact of the baseline echocardiogram in children with high-risk acute lymphoblastic leukemia

1 reference

12 December 2020

Dobutamine stress echocardiography in the evaluation of late anthracycline cardiotoxicity in childhood cancer survivors

1 reference

12 December 2020

Patient-specific electromechanical models of the heart for the prediction of pacing acute effects in CRT: a preliminary clinical validation

1 reference

12 December 2020

Cardiovascular T2-star (T2*) magnetic resonance for the early diagnosis of myocardial iron overload

1 reference

12 December 2020

Radionuclide angiography and endomyocardial biopsy in the assessment of doxorubicin cardiotoxicity

1 reference

12 December 2020

Evaluation of cardiac reserved function by high-dose dobutamine-stress echocardiography in asymptomatic anthracycline-treated survivors of childhood cancer

1 reference

12 December 2020

Cardiovascular effects in childhood cancer survivors treated with anthracyclines

1 reference

12 December 2020

Reduction of adriamycin to a semiquinone-free radical by NADPH cytochrome P-450 reductase produces DNA cleavage in a reaction mediated by molecular oxygen

1 reference

12 December 2020

Delayed enhancement in hypertrophic cardiomyopathy: comparison with myocardial tagging MRI

1 reference

12 December 2020

The Tei index of myocardial performance: applications in cardiology.

1 reference

12 December 2020

Sequential evaluation of left ventricular myocardial performance in children after anthracycline therapy.

1 reference

12 December 2020

T1, T2 relaxation and magnetization transfer in tissue at 3T

1 reference

12 December 2020

Sarcoplasmic reticulum genes are selectively down-regulated in cardiomyopathy produced by doxorubicin in rabbits

1 reference

12 December 2020

10.1007/S10554-013-0248-0

Identifiers

DOI

1 reference

Dimensions Publication ID

29 August 2017

1044039990

0 references

1 reference